-
Product Insights
Dadin Kowa
Dadin Kowa is a hydro project located in Gombe, Nigeria. The project is owned and developed by Mabon Ltd. The project came online in 2020. Empower your strategies with our Dadin Kowa report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Pemafibrate in Hypertriglyceridemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Pemafibrate in Hypertriglyceridemia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pemafibrate in Hypertriglyceridemia Drug Details: Pemafibrate (Parmodia) acts as dyslipidemic agent. It is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Pemafibrate in Primary Biliary Cholangitis (Primary Biliary Cirrhosis)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Pemafibrate in Primary Biliary Cholangitis (Primary Biliary Cirrhosis) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pemafibrate in Primary Biliary Cholangitis (Primary Biliary...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Pemafibrate in Hypercholesterolemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Pemafibrate in Hypercholesterolemia report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pemafibrate in Hypercholesterolemia Drug Details: Pemafibrate (Parmodia) acts as dyslipidemic agent. It...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ripasudil Hydrochloride Hydrate in Corneal Edema
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ripasudil Hydrochloride Hydrate in Corneal Edema report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ripasudil Hydrochloride Hydrate in Corneal Edema Drug Details: Ripasudil Hydrochloride...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – K-161 in Keratoconjunctivitis Sicca (Dry Eye)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - K-161 in Keratoconjunctivitis Sicca (Dry Eye) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. K-161 in Keratoconjunctivitis Sicca (Dry Eye) Drug Details: K-161 is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ABBV-637 in Non-Small Cell Lung Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. ABBV-637 in Non-Small Cell Lung Cancer Drug Details: ABBV-637 is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Povetacicept in Systemic Lupus Erythematosus
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Povetacicept in Systemic Lupus Erythematosus report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Povetacicept in Systemic Lupus Erythematosus Drug Details: Povetacicept is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – (Cefepime + Taniborbactam Hydrochloride) in Enterobacteriaceae Infections
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. (Cefepime + Taniborbactam Hydrochloride) in Enterobacteriaceae Infections Drug Details: Fixed dose combination of cefepime and...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ripasudil Hydrochloride Hydrate in Retinopathy Of Prematurity
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Ripasudil Hydrochloride Hydrate in Retinopathy Of Prematurity Drug Details: Ripasudil Hydrochloride hydrate (Glanatec) is a...